Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 2-Bromothiazole | HCID 76430 | — |
| Reactant | Lithium Chloride | HCID 433294 | — |
| Reactant | HCID 86724016 | HCID 86724016 | — |
| Reactant | HCID 178418918 | HCID 178418918 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 70980091 | HCID 70980091 | 75.3% |
Reaction Steps
2-Bromothiazole (0.500 g, 3.05 mmol) was dissolved in anhydrous THF (7.62 mL) and cooled to 4° C. (ice bath) under nitrogen. i-PrMgCl.LiCl in THF (2.0 M, 1.52 mL, 3.05 mmol) was added and the reaction stirred at this temperature for 30 minutes. The ice bath was removed and the reaction stirred for 30 minutes at room temperature. (2R,5R)-2-Formyl-5-methyl-piperazine-1,4-dicarboxylic acid di-tert-butyl ester (0.500 g, 1.52 mmol) was added and the reaction stirred for 2 h. The reaction mixture was quenched with water and extracted with DCM (3×). The combined organic extracts were dried with sodium sulfate, filtered and concentrated. Chromatography (silica gel, gradient elution, 0-100%, EtOAc in petrol 40-60) gave the title compound (473 mg). MS: [M+H]+=414.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09018214B2 |
|---|
| Source dataset | uspto-grants-2015_04 |
|---|
| ORD ID | ord-136ec6612238446aa41598375f74066c |
|---|
| Source note | uspto-grants-2015_04 |
|---|